Monday, January 10, 2011
Exelixis’ XL184 Granted Orphan Drug Designation and Assigned the Generic Name Cabozantinib
This is the trial drug that Tom is on. It now has a name other than XL-184! Click on the title to follow link.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment